QA: uniQure N.V. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001590560_2023_uniQure_N_V.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001590560, uniQure N.V.

  xvar xval
0 AssetsCurrent 476,774,000
1 IntangibleAssetsNetIncludingGoodwill 84,359,000
2 PropertyPlantAndEquipmentNet 50,532,000
3 remainder_Assets 93,299,000
4 LiabilitiesCurrent 75,919,000
5 LiabilitiesNoncurrent 153,036,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,254,000
8 SellingGeneralAndAdministrativeExpense 55,059,000
9 ResearchAndDevelopmentExpense 197,591,000
10 remainder_Expenses 13,143,000
11 remainder_Revenues 113,654,000
12 remainder_NetIncome 26,604,000
13 remainder_ComprehensiveNetIncome -29,435,000
  yvar yval
0 Assets 704,964,000
1 Liabilities 228,955,000
2 Expenses 267,047,000
3 Revenues 113,654,000
4 StockholdersEquity 476,009,000
5 NetIncome -126,789,000
6 ComprehensiveNetIncome -141,506,500
7 BaseVar 685,329,500
8 EconomicCapitalRatio 1.45

Edgar->Model Mapping

Feature Distribution

Change over Time